EP1171134A4 - Controlled release of sildenafil delivered by sublingual or buccal administration - Google Patents

Controlled release of sildenafil delivered by sublingual or buccal administration

Info

Publication number
EP1171134A4
EP1171134A4 EP00916328A EP00916328A EP1171134A4 EP 1171134 A4 EP1171134 A4 EP 1171134A4 EP 00916328 A EP00916328 A EP 00916328A EP 00916328 A EP00916328 A EP 00916328A EP 1171134 A4 EP1171134 A4 EP 1171134A4
Authority
EP
European Patent Office
Prior art keywords
sildenafil
sublingual
delivered
controlled release
buccal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00916328A
Other languages
German (de)
French (fr)
Other versions
EP1171134A1 (en
Inventor
Ragab El-Rashidy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pentech Pharmaceuticals Inc
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of EP1171134A1 publication Critical patent/EP1171134A1/en
Publication of EP1171134A4 publication Critical patent/EP1171134A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP00916328A 1999-03-16 2000-03-14 Controlled release of sildenafil delivered by sublingual or buccal administration Withdrawn EP1171134A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26895799A 1999-03-16 1999-03-16
PCT/US2000/006662 WO2000054777A1 (en) 1999-03-16 2000-03-14 Controlled release of sildenafil delivered by sublingual or buccal administration
US268957 2002-10-11

Publications (2)

Publication Number Publication Date
EP1171134A1 EP1171134A1 (en) 2002-01-16
EP1171134A4 true EP1171134A4 (en) 2005-01-05

Family

ID=23025240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00916328A Withdrawn EP1171134A4 (en) 1999-03-16 2000-03-14 Controlled release of sildenafil delivered by sublingual or buccal administration

Country Status (4)

Country Link
EP (1) EP1171134A4 (en)
JP (1) JP2002539165A (en)
AU (1) AU3744800A (en)
WO (1) WO2000054777A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199900061A (en) * 1998-05-15 2000-10-14 Pfizer PHARMACEUTICAL FORMULATIONS.
DE10244504A1 (en) * 2002-09-25 2004-04-08 Capsulution Nanoscience Ag Quick-release dosage form with poorly soluble active ingredient
US20070031349A1 (en) * 2005-06-23 2007-02-08 David Monteith Rapidly absorbing oral formulations of PDE 5 inhibitors
WO2007018057A1 (en) * 2005-08-05 2007-02-15 Freund Corporation Tablet rapidly disintegrating in the oral cavity and method of producing the same
KR101004205B1 (en) * 2008-12-17 2010-12-24 동아제약주식회사 The controlled released pharmaceutical compsitions of udenafil for sustained release property
DE102009016584A1 (en) * 2009-04-06 2010-10-07 Ratiopharm Gmbh Orodispersible tablet containing a sildenafil salt
MX2012001691A (en) * 2009-08-12 2012-02-29 Forest Lab Holdings Ltd Orally disintegrating compositions of linaclotide.
CN107722020A (en) * 2015-07-23 2018-02-23 青岛华之草医药科技有限公司 A kind of sildenafil citrate compound for treating male erectile dysfunction
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960621A2 (en) * 1998-05-15 1999-12-01 Pfizer Inc. Pharmaceutical formulations comprising sildenafil
EP0992240A1 (en) * 1997-05-29 2000-04-12 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for erection failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0992240A1 (en) * 1997-05-29 2000-04-12 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for erection failure
EP0960621A2 (en) * 1998-05-15 1999-12-01 Pfizer Inc. Pharmaceutical formulations comprising sildenafil

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0054777A1 *

Also Published As

Publication number Publication date
EP1171134A1 (en) 2002-01-16
WO2000054777A1 (en) 2000-09-21
AU3744800A (en) 2000-10-04
JP2002539165A (en) 2002-11-19

Similar Documents

Publication Publication Date Title
IL132646A0 (en) Controlled release of drugs delivered by sublingual or buccal administration
HK1048435A1 (en) Combined vaccine compositions
HK1090840A1 (en) Extended release oral dosage composition
HK1048253A1 (en) Oral formulations for anti-tumor compounds.
MXPA03002569A (en) Controlled release formulations for oral administration.
IL138192A0 (en) Controlled release oral dosage forms
EP1207852A4 (en) Controlled release oral dosage suitable for oral administration
EP1171134A4 (en) Controlled release of sildenafil delivered by sublingual or buccal administration
GB2346188A8 (en) Concentric offset riser
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
IL148908A0 (en) Oral controlled release formulations
EP1357898A4 (en) Improved controlled release oral dosage form
SI1017371T1 (en) Controlled release of drugs delivered by sublingual or buccal administration
SI1216032T1 (en) Oral controlled release formulations
SI0833619T1 (en) Controlled release of drugs delivered by sublingual or buccal administration
GB0014608D0 (en) Means for controlling release from oral dosage units
GB9916958D0 (en) Controlled release formulations
GB0009616D0 (en) Orthodontic brackets
GB9905347D0 (en) Tooth jet
GB0111389D0 (en) Controlled release formulations
GB9930455D0 (en) Vaccine compositions
GB9930456D0 (en) Vaccine compositions
GB9930457D0 (en) Vaccine compositions
GB9930458D0 (en) Vaccine compositions
GB9930459D0 (en) Vaccine compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20011011;LT PAYMENT 20011011;LV PAYMENT 20011011;MK PAYMENT 20011011;RO PAYMENT 20011011;SI PAYMENT 20011011

A4 Supplementary search report drawn up and despatched

Effective date: 20041123

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041001